Tag Archives: Against

Clovis investors lose faith as Rubraca struggles against Big Pharma’s marketing giants

It’s no secret that Clovis Oncology is up against some serious marketing muscle in the PARP inhibitor arena. And investors are doubting the company’s ability to hang in there. Shareholders headed for the exits Thursday after Clovis reported that Rubraca sales tallied just $ 33 million in the second quarter, coming in $ 2 million… Read More »

Viewpoints: Progress Against Opioid Epidemic Is Encouraging, But We Must Not Rest On Our Laurels Now

Opinion writers talk about the opioid crisis and other health care topics. The Washington Post: Opioid Deaths Are Down. But Challenges Continue. As the 20th century came to a close, the United States faced many challenges, but a high rate of death from prescription opioid overdoses was not one of them. In 1999, 3,442 people died… Read More »

Protein protects against non-alcoholic fatty liver disease

Researchers propose a possible therapeutic target to treat fatty liver, a disease for which there is currently no treatment. Non-alcoholic fatty liver disease describes several liver dysfunctions of varying severity, characterised by the accumulation of fat in hepatic cells and not caused by high alcohol consumption. This disease, one of the most common in developed… Read More »

Medical News Today: Marine bacteria offer new weapon against melanoma

A recent paper outlines how marine bacteria have inspired an entirely new way of fighting melanoma. The authors hope that their findings might eventually lead to a more effective treatment. Marine bacteria may provide a new weapon against melanoma. Skin cancer is by far the most common type of cancer. Melanoma accounts for just 1… Read More »